NCT02293590View on ClinicalTrials.gov

RICE: Remission by Intra-articular Injection Plus CErtolizumab

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 22, 2017

Study Completion Date

January 15, 2018

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Certolizumab Pegol

Trial Locations (1)

9007

Kantonsspital St. Gallen, Sankt Gallen

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Rüdiger B. Müller

OTHER

NCT02293590 - RICE: Remission by Intra-articular Injection Plus CErtolizumab | Biotech Hunter | Biotech Hunter